Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2001 Sep;134(2):241-5.
doi: 10.1038/sj.bjp.0704267.

A(1)-, A(2A)- and A(3)-subtype adenosine receptors modulate intraocular pressure in the mouse

Affiliations

A(1)-, A(2A)- and A(3)-subtype adenosine receptors modulate intraocular pressure in the mouse

M Y Avila et al. Br J Pharmacol. 2001 Sep.

Abstract

Despite the potential importance of the mouse in studying the pharmacology of aqueous dynamics, measurement of intraocular pressure (IOP) in its very small eye has been problematic. Utilizing a novel servo-null electrophysiologic approach recently applied to the mouse, we have identified a diversity of adenosine-receptor mechanisms in modulating IOP in this species. We report the first evidence that A(3) receptors increase IOP in any species, and verify in the mouse reports with larger mammals that A(1) receptors lower and A(2A) receptors increase IOP.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Means±s.e.mean of the responses to minimally effective concentrations of AR agonists and antagonists: 100 nM CPA, 100 nM DCPCX, 60 μM CGS 21680, 100 nM ZM241385, 200 nM Cl-IB-MECA, 140 nM IB-MECA, 25 μM MRS 1191, 11 μM MRS 1097, and 400 μM MRS 1523. At the extreme right of the bar graph, data are presented for 100 μM adenosine with and without pretreatment with the A3 AR antagonist MRS 1191.
Figure 2
Figure 2
Representative IOP tracings assessing effects of MRS 1191 and adenosine on mouse IOP. (a) MRS 1191 (25 μM) lowered baseline IOP by 2.62±0.04 mmHg, following which the response to 100 μM adenosine (+2.52±0.03 mmHg) was substantially attenuated; see, e.g., Figure 2b). (b) In the absence of the A3 antagonist, 100 μM adenosine consistently produced several-fold larger increases in IOP, in this eye raising IOP by 31.9±0.1 mmHg.

Similar articles

Cited by

References

    1. ASSEFF C.F., WEISMAN R.L., PODOS S.M., BECKER B. Ocular penetration of pilocarpine in primates. Am. J. Ophthalmol. 1973;75:212–215. - PubMed
    1. AVILA M.Y., CARRÉ D.A., STONE R.A., CIVAN M.M. Reliable measurement of mouse intraocular pressure by a servo-null micropipette system. Invest. Ophthalmol. Vis. Sci. 2001;42:1841–1846. - PubMed
    1. CARRÉ D.A., MITCHELL C.H., PETERSON-YANTORNO K., COCA-PRADOS M., CIVAN M.M. Adenosine activates Cl− channels of nonpigmented ciliary epithelial cells. Am. J. Physiol. 1997;273:C1354–1361. - PubMed
    1. CARRÉ D.A., MITCHELL C.H., PETERSON-YANTORNO K., COCA-PRADOS M., CIVAN M.M. Functional similarity of A3-adenosine and swelling-activated Cl− channels in nonpigmented ciliary epithelial cells. Am. J. Physiol. 2000;279:C440–C451. - PubMed
    1. CROSSON C.E. Adenosine receptor activation modulates introcular pressure in rabbits. J. Pharmacol. Exp. Ther. 1995;273:320–326. - PubMed

Publication types

LinkOut - more resources